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Objectives: We retrospectively analyzed lung biopsy specimens from patients who
underwent the Fontan procedure to identify predictive markers of outcome.
Methods: We studied the intra-acinar pulmonary arteries present in lung biopsy
specimens from 17 patients undergoing the Fontan procedure. We evaluated both
their morphology and their expression of endothelial nitric oxide synthase and
endothelin 1. We compared these data with those of 6 patients who died of no
pulmonary cause (control group).
Results: Eight patients had a good surgical outcome (group 1). Their distal arteries
were thin and weakly expressed endothelin 1 and endothelial nitric oxide synthase.
The procedure failed in 9 patients (group 2). Their distal arteries displayed muscle
extension with an increased wall thickness (P  .01 vs group 1). Their endothelin
1 expression remained low (not significant vs group 1). By contrast, endothelial
nitric oxide synthase was markedly overexpressed (P  .001 vs group 1).
Conclusion: Distal pulmonary arteries of patients in whom the Fontan procedure
failed exhibited a markedly increased wall thickness and a clear endothelial nitric
oxide synthase overexpression. In addition to giving clues to the pathogenesis of the
procedure’s failure, our study might help to define reliable predictive markers of its
outcome.
The Fontan operation has been shown to benefit patients with a singlefunctioning ventricle and low pulmonary resistance.1,2 The Fontanoperation is proposed to patients to separate the systemic venous andarterial circulations by means of direct anastomosis between thevena cava and the pulmonary arteries. Its outcome is highly depen-dent on several risk factors, chief of which is pulmonary vascular
resistance. Some patients have a poor outcome even when clinical and hemody-
namic parameters indicate that conditions for the Fontan procedure are ideal.3
Increased medial thickness of the intra-acinar pulmonary arteries is found in patients
with normal pulmonary pressure and might increase pulmonary vascular resistance
after cardiopulmonary bypass, leading to failure of the Fontan procedure.4 Predict-
ing the status of pulmonary vascular structure from hemodynamic data is very
difficult.5 Endothelial dysfunction could be involved in these patients.
The vascular endothelium is known to play a crucial role in the local regulation
of pulmonary vascular tone and in smooth muscle cell function.6-8 The vascular
endothelium produces and releases a variety of substances. Among them, nitric
oxide is a potent endothelium-derived vasorelaxant that prevents the proliferation of
smooth muscle cells.7 Endothelin 1 (ET-1) is also a potent endothelium-derived
peptide with vasoconstrictive and mitogenic properties.9,10 In adult patients with
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pulmonary hypertension, the expression of endothelial nitric
oxide synthase (eNOS) has been shown to decrease, and that
of ET-1 has been shown to increase.11,12
On the basis of these considerations, we postulated that
the pulmonary circulation was involved in failure of the
Fontan procedure, despite the satisfactory hemodynamic
criteria of the patients concerned. To support this hypothe-
sis, we attempted to determine whether the structure of the
pulmonary arteries or endothelial expression of vasoactive
substances were altered in these patients.
Methods
Study Population
The Fontan procedure is indicated for patients with a single func-
tioning ventricle or with complex congenital heart disease causing
similar impairment. It consists of anastomosing first the superior
vena cava and right pulmonary artery and then the inferior vena
cava and pulmonary artery with either an extracardiac tunnel or an
intracardiac conduit. Thus, the systemic venous circulation is
drained directly through the lungs and is totally separated from the
arterial circulation.
Of the 66 patients who underwent the Fontan procedure at the
Laennec and Necker-Enfants Malades hospitals between 1993 and
1999, 17 patients aged 2 to 23 years (median, 6 years) had a lung
biopsy analysis. The aim of the study was explained to only 30
patients and their families, depending on the impact of the surgeon
on the study, and the biopsy specimen was taken with their
agreement for 14 patients. We also analyzed 3 postmortem spec-
imens from patients who died as a result of the Fontan procedure
before the study period. The other patients underwent the Fontan
procedure without lung biopsy. No difference could be found
between the patients who underwent the Fontan procedure with or
without lung biopsy according to sex, age, and hemodynamic
parameters.
Of the 17 patients, the last 5 had a fenestrated Fontan operation.
The fenestration was chosen arbitrarily to facilitate the postoper-
ative course. We performed a histomorphometric analysis of these
specimens and used immunochemistry to assess eNOS and ET-1
expression.
The clinical and hemodynamic data for our 17 patients, includ-
ing previous surgical procedures, are shown in Table 1. All pa-
tients underwent cardiac catheterization before the Fontan proce-
dure with oxygen and nitric oxide challenge. The time period
between catheterization and lung biopsy was less than 1 month.
Because most children were referred from institutions in which the
techniques for measuring oxygen consumption in small children
were not always available, we reported their pulmonary pressures
and pulmonary/systemic flow ratios (Table 1). Patients were con-
sidered as good candidates for the Fontan procedure on the basis of
good ventricular function, absence of atrioventricular valve regur-
gitation, and indirect factors assuming low pulmonary resistance.
Because increased eNOS levels could be related to liver dysfunc-
tion, we evaluated liver function, which was normal in all patients.
Patients were retrospectively divided into 2 groups on the basis of
successful or unsuccessful surgical results. Group 1 comprised 8
patients aged 6 to 16 years (median, 10 years) with satisfactory
results, and group 2 comprised 9 patients aged 2 to 23 years
(median, 3.5 years) with poor results defined as takedown, pro-
longed pleural effusion requiring chest tube drainage for more than
14 days and hospitalization for more than 21 days, or death. With
the exception of age (10.4  3.7 vs 5.7  6.6 years, P  .04),
other factors, such as the hemoglobin level, saturation, and pul-
monary pressure (17.3  1.6 vs 17.4  1.3 g/dL [P  .76], 77.1%
 6.8% vs 75.1%  6.2% [P  .15], and 13.8  2.4 vs 14.4  3
mm Hg [P  .8], respectively), were comparable in both groups.
TABLE 1. Characteristics of patients with single ventricle
Patient
no. Sex
Additionnal
diagnosis
Previous
operation
Age
(y) Saturation
Catheterization results
Outcome/sat
Biopsy
grade
NOS
gradePAP SAP QP/QS VEDP
1 M TA, PA APS 9 78% 13 110/60 1.3 8 Good result 1 0.9
2 F MA, TGA, PS APS 7 80% 17 115/70 2 10 Good result N 0.9
3 M TA, PS None 16 62% 9 120/65 0.5 6 Good result, fen 1 0.3
4 F TGA PAB, PCPC 6 85% 13 115/70 1.4 9 Good result 1 0.9
5 M TA, PS APS 7 80% 14 100/55 1.5 8 Good result N 0.9
6 F TA, PA APS 11 78% 15 110/65 2 6 Good result, fen 1 0.5
7 F TA, PS None 14 74% 14 110/65 0.8 7 Good result 1 0.4
8 F PS None 13 80% 16 110/65 1.5 7 Pleural effusion, fen 2 1.1
9 F TA, TGA, PS None 5 75% 18 110/60 1.5 10 85%, fen N 1.4
10 M TGA PAB, PCPC 3.5 70% 11 100/50 0.8 10 60% then 83%, fen 2 2.5
11 F TA, PS None 2 74% 13 100/60 0.9 7 Take-down, fen 3 1.9
12 M TA, PS None 3 76% 13 110/65 1.5 6 Take-down, 85% 1 1.4
13 M TA PAB, PCPC 3 65% 14 95/60 0.8 8 Take-down, died 3 2
14 F TGA, PS APSx2 4 70% 18 100/65 1.7 7 Take-down, died 3 2
15 F PS APS 23 82% 10 130/70 NA 10 Take-down, died 4 2.2
16 M PS APS 6 84% 18 95/60 NA 6 Died 3 1.3
17 M None PAB, PCPC 2 80% 15 100/65 NA 10 Take-down, died 3 1.5
PAP, Pulmonary artery pressure; SAP, systemic artery pressure; QP/QS, pulmonary to systemic flow ratio; TA, tricuspid atresia; PA, pulmonary atresia; APS,
aortopulmonary shunt; MA, mitral atresia; TGA, transposition of great arteries; PS, pulmonary stenosis; N, normal; PAB, pulmonary artery banding; PCPC,
partial cavopulmonary connection; Fen, fenestarted Fontan operation; NA, not available.
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We did not find any difference in the previous surgical manage-
ment, the degree of pulmonary vascular bed protection, or the age
at the first operation that could explain the difference in outcome
of the Fontan procedure. In addition, no difference was observed in
the patients who had a fenestrated Fontan procedure (3 in group 1
and 2 in group 2). The myocardial protection and aortic crossclamp
times were comparable in all cases, and the postoperative man-
agement included pulmonary vasodilators, such as inhaled nitric
oxide and spontaneous breathing, if possible. All the patients had
postoperative measurement of the pressure in the Fontan circuit
and measurement of the transpulmonary gradient. The transpul-
monary gradient was significantly higher in group 2 patients than
in group 1 patients (P  .01). The takedown was decided on the
basis of hemodynamic deterioration with increased transpulmo-
nary gradient or increased left pulmonary pressure caused by
ventricular failure confirmed with the echocardiogram. Surgical
biopsy specimens were also analyzed from 6 control subjects (aged
3 months to 9 years; median, 0.5 years) who died of no pulmonary
cause (3 of sudden infant death syndrome and 3 of cerebral
tumors). Although patients who died of sudden infant death syn-
drome are younger than those in our patient population, we con-
sidered them as relevant control subjects because histomorphomet-
ric studies have shown that by the age of 4 to 6 months, arterial
structure is similar to that observed in older children.13
The lung biopsy specimens were taken from the lower lobes
when the lung was inflated, and tissues were fixed in 10% buffered
formalin solution and embedded in paraffin for routine pathologic
examination and immunohistochemical analysis.
Histomorphometric Study
Serial paraffin-embedded 4-m-thick sections were stained with
hematoxylin and eosin, Perls stain for iron, and modified orcein for
elastic fibers. In each biopsy specimen the pulmonary vascular
structure was analyzed by using quantitative morphometric tech-
niques, as previously described.13-15 Pulmonary arterial muscular-
ity was assessed by determining the mean percentage arterial
medial thickness of at least 40 arteries in different size ranges and
was compared with the normal values for age. The proportion of
muscular, partially muscular, and nonmuscular arteries accompa-
nying terminal and respiratory bronchioles and alveolar ducts was
also assessed to evaluate potential muscle extension to more pe-
ripheral arteries than is normal for age. In each biopsy specimen
the size of the intra-acinar arteries was determined by measuring
the external diameter of all intra-acinar arteries cut in a perpen-
dicular fashion. We calculated the mean external diameter at each
airway level. The measurements were performed by 2 blinded
observers. Because the Heath-Edwards grades are inappropriate
for assessing pulmonary hypertension in congenital heart disease
and because the Rabinovitch classification concerns more severe
lesions than that observed in our population, we scored the mor-
phometric grades of lung biopsy specimens as follows: normal,
normal arterial medial thickness of proximal and distal pulmonary
arteries with no intimal damage (Figure 1, A); grade 1, medial
hypertrophy of proximal arteries less than 2 normal but normal
medial thickness of distal arteries accompanying alveolar ducts
and alveolar walls; grade 2, medial hypertrophy of proximal and
distal pulmonary arteries less than twice the normal wall thickness;
grade 3, medial hypertrophy of proximal and distal arteries more
than twice the normal wall thickness (Figure 1, B); and grade 4,
intimal thickening.
Grades 1 and 2 are not described in the Rabinovitch classifi-
cation, and grade 3 would correspond to its grade A.16
Immunohistochemical Analysis
Serial paraffin sections of lung tissue were immunostained with
antiserum to human eNOS (Transduction Laboratory) and to ET-1
(affinity bioreagent, Golden). All the slides were stained and
developed at the same time to avoid variability. Tissue sections
were deparaffinized in toluene, rehydrated through graded concen-
trations of ethanol to water, and heated for 40 minutes in buffered
citrate at pH 6. Slides were incubated in hydrogen peroxide to
block endogenous peroxidase activity, washed in Tris-buffered
saline solution, and incubated for 1 hour with anti-NOS (diluted
1:100) or anti-ET-1 (diluted 1:200) primary antibodies or with
normal serum used as a negative control. Sections were then
incubated for 15 minutes with a biotinylated secondary antibody
Figure 1. Light microscopy patterns of lung biopsies performed during Fontan procedures. (Original magnification
for all panels 400.) A, Normal nonmuscularized alveolar duct artery (arrowheads). B, Extension of muscle into the
distal alveolar duct artery. Note the presence of muscle between the 2 laminae (arrowheads).
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and stained with streptavidine labeled with peroxidase, according
to the manufacturer’s instructions (Dako Corp). Slides were coun-
terstained with Harris hematoxylin. Three investigators blinded to
all clinical information examined all the slides to assess interob-
server variations. They used a semiquantitative system to grade the
staining intensity (0, no staining; 4, maximal staining). No signif-
icant difference between observers was noted. The staining was
evaluated for both the proximal (100 m) and distal (50-
100_m) intra-acinar arteries and the capillaries. Because the
immunostaining was similar in different-sized arteries, we pooled
these results. We retrospectively assigned the data to the patients
and divided them into 3 groups (group 1, group 2, and the control
group). We expressed the results as a score (mean  SD of
determinations performed on 20 arteries by all investigators).
Statistical Analysis
Results are expressed as means  SD. The significance of differ-
ences between groups was assessed by the Student t test or Fisher
exact test, as appropriate. The Pearson coefficient was used to
calculate correlations.
Results
Histomorphometric and immunohistochemical studies were
performed on 14 lung biopsy specimens taken during the
Fontan procedure and on 3 postmortem specimens (patients
15-17).
Histomorphometric Study
Histomorphometric study data are shown in Figures 1 and 2.
Seven of the 8 patients who had good outcomes (group 1)
exhibited normal distal intra-acinar pulmonary arteries (ex-
ternal diameter, 50 m), and 1 patient exhibited muscle
extension into the distal arteries. This patient had postoper-
ative pleural effusion for 12 days. In this group the percent-
age wall thickness of the distal arteries was low (9.6% 
2.5%) and was comparable with normal values for age.13
All patients exhibited a small increase in proximal intra-
acinar artery thickness, but the difference versus values in
the normal control subjects was not significant.
In contrast, 7 of the 9 patients with poor results (group 2)
exhibited muscle extension of grade 2 or 3 in distal intra-
acinar pulmonary arteries, whereas only 2 of them had
normal distal pulmonary arteries. As a whole, the mean
percentage wall thickness of the distal pulmonary arteries
was markedly increased in group 2 (20.45%  7.1%, P 
.01 compared with group 1; Figure 2).
It is noteworthy that none of the patients with normal
criteria for the distal intra-acinar pulmonary artery died of
the Fontan procedure, whereas 5 of the 8 with grade 2 or
greater muscle extension died shortly thereafter (P  .001).
Immunohistochemical Study
NOS immunostaining. In the control group eNOS reac-
tivity was low in the pulmonary arteries (score, 0.88 0.32;
Figure 3, A) and mainly observed in endothelial cells of the
proximal and distal muscular pulmonary arteries and capil-
laries. Endothelial NOS was also detected in the bronchiolar
epithelium to a lesser extent. No difference was noted
between the proximal and distal pulmonary arteries regard-
ing the staining intensity (Figure 4).
In group 1 patients immunostaining for eNOS was very
weak (score, 0.86 0.35; Figure 3, B) and similar to that of
the control group, with no difference between the proximal
and distal pulmonary arteries (Figure 4).
In contrast, group 2 patients exhibited a strong eNOS
immunoreactivity in the pulmonary vascular endothelium of
their proximal and distal intrapulmonary arteries (score,
1.86  0.88; P  .01 vs group 1; Figure 3, C).
Figure 2. Relationship between the percentage wall thickness of the distal pulmonary arteries (external diameter
<50 m, 50-100 m, or 100-200 m) and outcome of the Fontan procedure. NS, Not significant. *P < .01, P <
.05.
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There was a good correlation between the histomorpho-
metric and immunohistochemical results, except for patients
8 and 9 (r  0.76, P  .001; Figure 5).
Endothelin immunostaining. Endothelin immunostain-
ing data are shown in Figure 6.
In the control group ET-1 immunoreactivity was weak in
both the proximal and distal muscular pulmonary arteries
and mainly observed in endothelial and smooth muscle cells
of muscular pulmonary arteries, capillaries, inflammatory
cells, and type II pneumocytes. In epithelial cells immuno-
reactivity was strong in all patients.
In group 1 ET-1 expression remained low (score, 0.9 
0.3) and comparable with that of the control subjects (0.7 
0.2), whereas group 2 patients exhibited a more intense
ET-1 immunoreactivity (score, 1.3  0.3) than the control
subjects (P  .01). The difference between immunoreactiv-
ity observed in the proximal pulmonary arteries of groups 1
and 2 was not significant (Figure 6).
Discussion
The Fontan procedure has been proposed for the correction
of complex cardiac lesions for which biventricular repair is
impossible. In the absence of a pulmonary ventricle, even a
slight increase in pulmonary vascular resistance can result
in failure of the procedure. In our study, as reported by
others, we observed that the Fontan procedure failed in
some patients despite fulfilment of the usual hemodynamic
criteria. Predictive factors of outcome are presently lacking.
Failure of the Fontan procedure is frequently due to in-
creased pulmonary resistance after cardiopulmonary by-
pass.
We postulated that endothelial dysfunction might be at
least partly responsible for this situation.
To find out whether markers of such dysfunction could
be evidenced in patients with a failed procedure, we retro-
spectively evaluated the pulmonary vascular structure and
the expression of endothelial vasoactive factors in lung
biopsy specimens obtained during surgical intervention
from patients undergoing the Fontan procedure. For this
purpose, we used both histomorphometric criteria and im-
munohistochemical markers of eNOS and ET-1 expression
on endothelium.
We could not find any differences between group 1 and
2 patients that were predictive of these histologic and im-
munohistochemical changes. Indeed, saturation, degree of
pulmonary protection, surgical technique, aortic cross-
Figure 3. Immunohistochemical studies showing eNOS expression in the pulmonary arteries: A, healthy control
patients; B, group 1 patients (successful Fontan procedures); C, group 2 patients (failed Fontan procedures).
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clamping time, and postoperative management were com-
parable in both groups. The only difference between groups
is age. However, we would expect the opposite because the
younger age of group 2 is usually recommended to avoid
alteration of pulmonary vascular resistance or ventricular
failure.
Our results showed abnormal muscle extension into the
distal pulmonary arteries of the majority of patients in
whom surgical intervention failed. Indeed, although group 1
patients exhibited normal distal pulmonary artery muscular-
ity in all but one patient, 7 of the 9 patients in group 2 had
muscle extension in the distal pulmonary arteries of grade 2
or greater. It should be underlined that most of these sam-
ples would have been considered as normal by using stan-
dard pathologic criteria because the changes in the muscu-
larity of the distal pulmonary arteries were minor. However,
these arteries contribute greatly to pulmonary vascular re-
sistance and to failure of the Fontan procedure because of an
impaired vascular reactivity after a stimulus such as cardio-
pulmonary bypass.
We also postulated that expression of endothelial vaso-
active factors might be altered in patients in whom the
procedure failed, as observed in patients with pulmonary
hypertension.11,12 Immunoreactivity was indeed weak for
both eNOS and ET-1 in group 1 patients and similar to that
of the control group. By contrast, eNOS was intensely
expressed in the vascular endothelium of group 2. Endothe-
lial NOS expression was comparable all along the arterial
axis. It was significantly stronger in group 2 patients than in
group 1 patients and control subjects. It should be under-
lined that this criterion might appear as more sensitive than
histomorphometry. Indeed, patients 9 and 12 had normal
distal wall thickness but increased eNOS reactivity, and
their operations failed. Patient 8 had thick-walled distal
pulmonary arteries with only a slight increase in NOS
expression. This patient had an overall good outcome, de-
spite a pleural effusion for 12 days.
Altogether, all 9 patients whose Fontan procedures failed
exhibited a marked expression of NOS and ET-1 compared
Figure 4. NOS immunostaining score in proximal (prox) and distal (dist) intra-acinar pulmonary arteries and
capillaries (cap) in group 1 patients (successful Fontan procedures) and group 2 patients (failed Fontan procedures)
versus that in normal control subjects. NOS expression is stronger in group 2 patients than in group 1 patients and
normal control subjects. *P < .01.
Figure 5. Correlation between histomorphometric and immunohis-
tochemical data.
Surgery for Congenital Heart Disease Le´vy et al
1088 The Journal of Thoracic and Cardiovascular Surgery ● May 2003
CH
D
with that seen in the control subjects, despite a low pulmo-
nary pressure.
Overexpression of endothelial factors in patients with
failure of the procedure might indicate an endothelial dys-
function. Increased shear stress caused by abnormal pulmo-
nary blood flow, and polycythemia might cause endothelial
dysfunction with overstimulation of the nitric oxide path-
way to maintain low pulmonary pressure. Endothelial NOS
is indeed upregulated in shunt-induced pulmonary hyper-
tension in lambs, in rats exposed to hypoxia, and in poly-
cythemic rats.17-20 By contrast, in adult patients with pul-
monary hypertension, eNOS expression is reduced.11,12 The
mechanism underlying pulmonary hypertension might be
involved in the differences between endothelial factor syn-
thesis because eNOS is upregulated in shunt-induced pul-
monary hypertension, whereas it is reduced in ductus arte-
riosus ligation.17,21 However, 4 patients with successful
operations had increased pulmonary blood flow without the
eNOS overexpression observed in all patients in whom
surgical intervention failed. Therefore, increased pulmonary
blood flow does not necessarily impair endothelial func-
tions. Unlike adult patients with primary pulmonary hyper-
tension, the eNOS is upregulated in our patients with failed
Fontan procedures. This could be due to an attempt to
improve the pulmonary vascular resistance and facilitate the
Fontan circulation. Indeed, adult patients with primary pul-
monary hypertension could have an incapacity to produce
eNOS, which is not the case in our population. Whether this
upregulation of eNOS is to balance the endothelin produc-
tion or the lack of other vasodilative substances remains to
be elucidated.
Of interest is the fact that histomorphometric and immu-
nohistochemical data were correlated (P  .001). The
former data appear to have a good predictive value, but the
latter might be more sensitive. Bearing in mind that immu-
nohistochemistry only allows for a semiquantitative assess-
ment of protein expression, we are currently investigating
the possibility of more accurate procedures, Western blot-
ting, and enzyme-linked immunosorbent assay to quantify
eNOS activity and ET-1 on frozen tissues.
The results of this study warrant further investigation of
these markers by a prospective study of patients considered
good candidates for the Fontan procedure. Our results might
support the idea that this procedure should be performed in
2 steps, with a lung biopsy performed during the first step
(ie, the partial cavopulmonary connection). This sample
would undergo histomorphometric studies, immunohisto-
chemical studies, and quantification of eNOS and ET-1, and
the decision concerning whether to complete the procedure
would be based on the absence of endothelial dysfunction.
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